Lama Ghazi, MD, PhD

Hypertension; Nephrology; Electronic Health Records

Epidemiology Methods; Health Equity, Disparities, Social Determinants and Justice

• Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.Ghazi L, Cohen LP, Muntner P, Shimbo D, Drawz PE. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study. Hypertension 2020, 76:1090-1096.
• Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.Soliman EZ, Rahman AF, Zhang ZM, Rodriguez CJ, Chang TI, Bates JT, Ghazi L, Blackshear JL, Chonchol M, Fine LJ, Ambrosius WT, Lewis CE. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation. Hypertension 2020, 75:1491-1496.
• Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD.Ghazi L, Yaffe K, Tamura MK, Rahman M, Hsu CY, Anderson AH, Cohen JB, Fischer MJ, Miller ER, Navaneethan SD, He J, Weir MR, Townsend RR, Cohen DL, Feldman HI, Drawz PE. Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clinical Journal Of The American Society Of Nephrology : CJASN 2020, 15:455-464.
• Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial. American Journal Of Hypertension 2020, 33:43-52.
• Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE. Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT. Journal Of The American Heart Association 2019, 8:e011706.
• Race, Sex, Age, and Regional Differences in the Association of Obstructive Sleep Apnea With Atrial Fibrillation: Reasons for Geographic and Racial Differences in Stroke Study.Ghazi L, Bennett A, Petrov ME, Howard VJ, Safford MM, Soliman EZ, Glasser SP. Race, Sex, Age, and Regional Differences in the Association of Obstructive Sleep Apnea With Atrial Fibrillation: Reasons for Geographic and Racial Differences in Stroke Study. Journal Of Clinical Sleep Medicine : JCSM : Official Publication Of The American Academy Of Sleep Medicine 2018, 14:1485-1493.
• Impact of the SPRINT Trial on Hypertension Management.Ghazi L, Oparil S. Impact of the SPRINT Trial on Hypertension Management. Annual Review Of Medicine 2018, 69:81-95.
• Response to letter to Editor "Lessons learned from the recent history of technologies for non-invasive estimation of aortic blood pressure using transfer functions and pulse wave analysis" by Papaioannou et al.Ghazi L, Hage FG. Response to letter to Editor "Lessons learned from the recent history of technologies for non-invasive estimation of aortic blood pressure using transfer functions and pulse wave analysis" by Papaioannou et al. Journal Of The American Society Of Hypertension : JASH 2017, 11:321-322.
• Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation 2017, 136:440-450.
• Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.Ghazi L, Drawz P. Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Research 2017, 6.
• Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.Ghazi L, Oparil S, Calhoun DA, Lin CP, Dudenbostel T. Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant. Hypertension 2017, 69:827-835.
• 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension. American Journal Of Hypertension 2017, 30:518-523.
• Assessment of vascular function in low socioeconomic status preschool children: a pilot study.Ghazi L, Dudenbostel T, Xing D, Ejem D, Turner-Henson A, Joiner CI, Affuso O, Azuero A, Oparil S, Calhoun DA, Rice M, Hage FG. Assessment of vascular function in low socioeconomic status preschool children: a pilot study. Journal Of The American Society Of Hypertension : JASH 2017, 11:101-109.
• BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?Bhatt H, Ghazi L, Calhoun D, Oparil S. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out? Current Cardiology Reports 2016, 18:98.
• Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.Dudenbostel T, Ghazi L, Liu M, Li P, Oparil S, Calhoun DA. Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension. Hypertension 2016, 68:995-1003.
• Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.Ghazi L, Safford MM, Khodneva Y, O'Neal WT, Soliman EZ, Glasser SP. Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study. Journal Of The American Society Of Hypertension : JASH 2016, 10:625-632.e1.
• Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.Ghazi L, Dudenbostel T, Lin CP, Oparil S, Calhoun DA. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status. Journal Of Hypertension 2016, 34:1005-10.
• Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery.Ghazi L, Schwann TA, Engoren MC, Habib RH. Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery. Thrombosis Research 2015, 136:1204-10.
• Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study.O'Neal WT, Qureshi W, Judd SE, Glasser SP, Ghazi L, Pulley L, Howard VJ, Howard G, Soliman EZ. Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study. Annals Of Behavioral Medicine : A Publication Of The Society Of Behavioral Medicine 2015, 49:802-8.